Alfresa Holdings Corporation
World Rank (Aug-2026)
5,613
Market Cap (Aug-2026)
2.489 Billion USD
World Rank (Jan-05-2024)
4,268
Market Cap (Jan-05-2024)
3.106 Billion USD
World Rank (Jul-30-2023)
4,263
Market Cap (Jul-30-2023)
3.089 Billion USD
World Rank (Dec-25-2022)
5,180
Market Cap (Dec-25-2022)
2.159 Billion USD
World Rank (Jan-07-2022)
5,016
Market Cap (Jan-07-2022)
2.86 Billion USD
Annual Revenue in USD
18,867 Million USD
Annual Net Income in USD
235 Million USD
Annual Results for Period Ending
Mar-2022 ending year
Company Profile
ALFRESA HOLDINGS CORPORATION deals with wholesaling, manufacturing, marketing and import/export of pharmaceuticals, diagnostic reagents, medical devices/equipment, etc., and operating dispensing pharmacies and conducting related businesses. The company annual revenue is 2,698.5 billion JPY, annual net income is 40.2 billion JPY, annual operating income is 47.6 billion JPY, total assets is 1,351.6 billion JPY, total liabilities is 876.7 billion JPY, total equity is 473.7 billion JPY as on 2020. The headquarters is in Japan.
Company Website